Esophagogastric junction distensibility assessed with an endoscopic functional luminal imaging probe (EndoFLIP)
Background
Increased esophagogastric junction (EGJ) compliance is a key abnormality in GERD leading to increased volumes of reflux. To date, EGJ distensibility has been measured only with investigational barostat-based prototype devices.
Objectives
The aim of the study was to test the endoscopic functional luminal imaging probe (EndoFLIP), a new commercially available technology designed to measure intraluminal distensibility, by assessing the EGJ of GERD patients and controls.
Design
Prospective case-control series.
Setting
Tertiary referral center.
Subjects
Twenty GERD patients and 20 controls studied during a routine esophagogastroduodenoscopy.
Methods
The EndoFLIP was passed through the endoscopic instrumentation channel and positioned across the EGJ. The EndoFLIP uses impedance planimetry to measure 16 cross-sectional areas (CSA) along with the corresponding intrabag pressure within a 4.6-cm cylindrical segment of a fluid-filled bag.
Main Outcome Measurement
EGJ distensibility was assessed with 10- to 40-mL volume-controlled distentions.
Results
In both groups, the least distensible locus at the EGJ was usually at the hiatus. As a group, GERD patients exhibited two- to threefold increased EGJ distensibility compared with controls, particularly at 20- to 30-mL distention volumes, values quantitatively similar to previous measurements with barostat-based devices. The endoscopic estimation of EGJ distensibility, the flap valve grade, correlated poorly with EndoFLIP measurements.
Limitations
Heterogeneity of GERD patients.
Conclusions
Measurement of EGJ distensibility with EndoFLIP is feasible during clinical endoscopy. Stratifying GERD patients according to this physiological parameter may facilitate the identification of patient subgroups responsive or unresponsive to medical or surgical treatments.
Abbreviations: CSA, cross-sectional area, EGJ, esophagogastric junction, FLIP, functional luminal imaging probe, LES, lower esophageal sphincter
To access this article, please choose from the options below
DISCLOSURE: The following author disclosed a financial relationship relevant to this publication: J.E. Pandolfino Scientific Advisory Board member, Crospon Ltd. The other authors disclosed no financial relationships relevant to this publication. Supported and sponsored by Crospon Ltd, Galway, Ireland; grant R01 DC00646 (P.J. Kahrilas and J.E. Pandolfino) from the Public Health Service; and the 2008 AGA June and Donald O. Castell Esophageal Clinical Research Award (J.E. Pandolfino).
PII: S0016-5107(10)00142-2
doi:10.1016/j.gie.2010.01.069
© 2010 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.
